A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Completed · Phase 2
Conditions studied: Alzheimer's Disease, Mild Cognitive Impairment
In brief
Evaluate 18F-AV-45 positron emission tomography (PET) imaging for distinguishing healthy control subjects, from subjects with Alzheimer's disease (AD) or Mild cognitive impairment (MCI).
Key facts
- Study ID
- NCT00702143
- Run by
- Avid Radiopharmaceuticals
- People needed
- 184
- Starts
- 2008-06-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2012-05-10
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Have a history or current diagnosis of other neurologic disease
- Have had or currently have a diagnosis of other neurodegenerative disease
- Have participated in experimental therapy targeted to amyloid plaque
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — Scottsdale, Arizona, United States
- Research Site — Sun City, Arizona, United States
- Research Site — Tucson, Arizona, United States
- Research Site — Costa Mesa, California, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Hallandale, Florida, United States
- Research Site — Miami Beach, Florida, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Sunrise, Florida, United States
- Research Site — West Palm Beach, Florida, United States
- Research Site — Albany, New York, United States
- Research Site — Winston-Salem, North Carolina, United States
- Research Site — Jenkintown, Pennsylvania, United States
- Research Site — Bennington, Vermont, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.